• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Y-Mabs Therapeutics Inc (NQ: YMAB )

    15.55 -0.14 (-0.89%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Y-Mabs Therapeutics Inc

    < Previous 1 2 3 4 5 6 Next >
    US Stocks Start Week On Lower Note; Dow Dips Over 200 Points
    U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Monday. 
    Via Benzinga
    Where Y-mAbs Therapeutics Stands With Analysts
    Within the last quarter, Y-mAbs Therapeutics (NASDAQ:YMAB) has observed the following analyst ratings: 
    Via Benzinga
    Grainger To Surge Over 11%? Plus This Analyst Predicts $230 For Caterpillar
    UBS raised the price target on Caterpillar Inc. (NYSE: CAT) from $225 to $230. Caterpillar shares fell 1.1% to $216.85 in pre-market trading. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Gainers PLx Pharma (NASDAQ:PLXP) stock increased by 15.5% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $20.3 million. 
    Via Benzinga
    TuSimple, Y-mAbs Therapeutics And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
    U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Welcome back and get ready for another week of trading as we break down the biggest pre-market stock movers for Monday morning! 
    Via InvestorPlace
    Why Quanergy Systems Shares Are Trading Sharply Lower; Here Are 28 Stocks Moving Premarket
    Gainers Selina Hospitality PLC (NASDAQ: SLNA) rose 31.9% to $19.90 in pre-market trading after dipping around 63% on Friday. 
    Via Benzinga
    FDA's AdComm Gives Thumbs Down To Pediatric Cancer Therapy
    FDA's Oncologic Drugs Advisory Committee (ODAC) raised concerns regarding the efficacy of Y-mAbs Therapeutics Inc's (NASDAQ: YMAB) potential pediatric neuroblastoma treatment, omburtamab. 
    Via Benzinga
    Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
    Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Gainers 
    Via Benzinga
    Why UserTesting Shares Are Trading Higher By Around 93%? Here Are 53 Stocks Moving In Thursday's Mid-Day Session
    Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 111% to $2.03 after the company announced it entered into a license agreement with Transcosmos Digital Technology for its Apromore process... 
    Via Benzinga
    INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Y-mAbs Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
    Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the... 
    Via Benzinga
    Lost Money in Y-mAbs Therapeutics, Inc.?
    From Gibbs Law Group
    Via Business Wire
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Y-mAbs Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Gainers 
    Via Benzinga
    AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
    Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the... 
    Via Benzinga
    Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
    Via Benzinga
    FDA Advisory Committee Meeting Scheduled For October 28, 2022 To Review Y-mAbs' Refiling For Omburtamab
    The Oncologic Drugs Advisory Committee (ODAC) of the U.S. 
    Via Benzinga
    Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
    Via Benzinga
    Y-mAbs Gets Regulatory Approval In Israel For Neuroblastoma Candidate
    The Israeli Ministry of Health has approved Y-mAbs Therapeutics’ (NASDAQ: YMAB) lead drug DANYELZA in combination with granulocyte-macrophage colony-stimulating factor for pediatric patients 1 year of... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022
    Upgrades 
    Via Benzinga
    The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
    Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:... 
    Via Benzinga
    Earnings Scheduled For August 8, 2022
    Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter. 
    Via Benzinga
    103 Biggest Movers From Yesterday
    Gainers 
    Via Benzinga
    77 Stocks Moving In Tuesday's Mid-Day Session
    Gainers 
    Via Benzinga
    The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Earnings Scheduled For May 9, 2022
    Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million. 
    Via Benzinga
    74 Biggest Movers From Yesterday
    Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric... 
    Via Benzinga
    48 Stocks Moving In Thursday's Mid-Day Session
    Gainers T Stamp Inc. (NASDAQ: IDAI) shares jumped 201% to $6.33. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric MFATM) solution. Statera... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.